logo

CTKB

Cytek Biosciences·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
5.12 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Should I Buy CTKB Now?
  • Based on a composite score of 5.12/10, we rate CTKB as a Netural. Our analysis breaks down into 9.62/10 for Fundamentals, 3.32/10 for Technicals, and 3.77/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is CTKB fundamentally strong?
What is the current technical signals for CTKB?
What is the market sentiment for CTKB?